Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin‐3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Hepatology Research · 2026-11 · 56 (11) · 1614-1631
DOI: 10.1111/hepr.70234 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatology Research, online erschienen am 11.07.2026. Verfasst von Emi Sometani und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, The University of Osaka Graduate School of Medicine, Osaka, Japan. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Background and Aim Although nucleos(t)ide analog (NUC) therapy reduces hepatocellular carcinoma (HCC) incidence in chronic hepatitis B (CHB) patients, HCC can develop despite viral suppression. Identifying predictive biomarkers of HCC during NUC therapy remains clinically important. This study aimed to identify novel biomarkers by proteomic analysis of serum extracellular vesicle (EV) proteins in CHB patients receiving NUC therapy.
Methods
We enrolled 242 CHB patients treated with NUCs for over one year, with serum HBV DNA < 3.0 log IU/mL, no prior HCC, and available stored serum samples. Proteomic analysis of serum EV proteins was carried out to identify candidate biomarkers, followed by validation of their serum levels using enzyme‐linked immunosorbent assay (ELISA).
Results
The median age was 55 years; 144 were male. During a median follow‐up of 10.1 years, 44 patients (18.2%) developed HCC. Five candidate EV proteins were identified: fibulin‐3, VCAM‐1, fibronectin, vWF, and FGFBP2. In univariate Cox analysis of serum levels of candidate EV proteins measured by ELISA, fibulin‐3 and VCAM‐1 were identified as significant predictive factors. In multivariate analysis, male sex, GGT, AFP, fibulin‐3, and the FIB‐4 index were independent predictors, whereas VCAM‐1 was not. A cutoff value for fibulin‐3 was set at 10.8 μg/mL. HCC incidence was significantly higher in patients with fibulin‐3 ≥ 10.8 μg/mL and in those with ≥ 3 of five identified risk factors. The 10‐year cumulative HCC incidence was 0% versus 37.2% in patients with 0 versus ≥ 3 risk factors.
Conclusion
Serum fibulin‐3 is a novel biomarker predictive of HCC in CHB patients undergoing NUC therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
- Laboratory of Proteomics for Drug Discovery, Center for Drug Design Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
- Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
- Department of Gastroenterology and Hepatology, NHO Osaka National Hospital, Osaka, Japan.
- Department of Medical Innovation, The University of Osaka Hospital, Osaka, Japan.
ORCID-Profile: Kazuhiro Murai, Hayato Hikita, Hidenori Toyoda, Shinji Kuriki, Kazuki Maesaka, Yuki Tahata, Yoshinobu Saito, Takahiro Kodama, Ryotaro Sakamori
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Sometani, E., Murai, K., Hikita, H., Sung, J., Muraoka, S., Toyoda, H., Tanaka, S., Miyake, T., Kuriki, S., Fukumoto, K., Shigeno, S., Myojin, Y., Maesaka, K., Shirai, K., Makino, Y., Tahata, Y., Saito, Y., Kodama, T., Sakamori, R., …, & Takehara, T. (2026). Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin‐3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. Hepatology Research, 56(11), 1614-1631. https://doi.org/10.1111/hepr.70234
Vancouver
Sometani E, Murai K, Hikita H, Sung J, Muraoka S, Toyoda H, et al. Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin‐3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. Hepatology Research. 2026;56(11):1614-1631. doi:10.1111/hepr.70234
BibTeX
@article{Sometani2026,
author = {Sometani, Emi and Murai, Kazuhiro and Hikita, Hayato and Sung, Jihyun and Muraoka, Satoshi and Toyoda, Hidenori and Tanaka, Satoshi and Miyake, Takayuki and Kuriki, Shinji and Fukumoto, Kenji and Shigeno, Satoshi and Myojin, Yuta and Maesaka, Kazuki and Shirai, Kumiko and Makino, Yuki and Tahata, Yuki and Saito, Yoshinobu and Kodama, Takahiro and Sakamori, Ryotaro and Adachi, Jun and Yamada, Tomomi and Takehara, Tetsuo},
title = {Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin‐3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B},
journal = {Hepatology Research},
year = {2026},
volume = {56},
number = {11},
pages = {1614--1631},
doi = {10.1111/hepr.70234}
}
EUVIMED